ASHBURN, Va., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX), a clinical-stage specialty pharmaceutical company focused on novel treatments for rare and orphan diseases, today announced that it has initiated the testing of the safety and efficacy of QRX003 in a young child with Netherton Syndrome (NS),… Read More..

MILTON, N.Y., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced that its Board of Directors has authorized the repurchase of up to $2.0 million of Sono-Tek’s outstanding common stock (the “Repurchase Program”). Dr. Christopher L Coccio, Executive… Read More..

MILTON, N.Y., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced its participation in Spartan Capital Securities, LLC's inaugural investor conference on November 4that the Pierre Hotel in New York. Steve Harshbarger, CEO & President of Sono-Tek will provide… Read More..